Digital Productivity
Organizations
Conferences
Info & Opinion
May 17, 2008
A few news bulletins on Synteract, Pharm-Olam, Taridium, Quintiles, Eidetics, CRI Worldwide, WuXi PharmaTech and MakroCare.
A few news bulletins on Commonwealth Biotechnologies, Venturepharm Laboratories, chronic disorganization, PanGenex, Particle Sciences, Thomson Reuters and Lance Armstrong.
A few news bulletins on ACRO, Kendle, etrials, eResearch Technology, Integrium and Covance.
With bulletins about Covance, NovaRx, Jordan, FDA and Medidata Solutions.
A few news bulletins on Wyeth, Pfizer, Kansas, Parexel, SeraCare, Tigermed Consulting, Sundia Meditech, HD BioSciences, Merck and NovaSecta.
Covance allowed a tour of a controversial Arizona lab for animal testing. “We always anticipate that there will be protests,” said Camilla Strongin, a spokeswoman for Covance’s public relations and lobbying firm, the Symington Group, chaired by former state governor Fife Symington. Here’s the story. NovaRx selected two elements of… more...
Industry titan Robert Ruffalo is stepping down from head of R&D at Wyeth. “"Bob Ruffolo has been the driving force of our R&D progress, establishing Wyeth as one of the research leaders in the pharmaceutical industry,” said Bernard Poussot, Wyeth’s president and CEO. “His legacy will be our pipeline, recognized… more...
Veeda Clinical Research, a full service contract research organization, announced the launch of a global oncology CRO. Veeda Oncology aims to provide oncology clinical research services internationally. Said Binoy Gardi, group MD at Veeda Clinical Research: “Since July 1, 2007, we have been establishing the infrastructure for a global oncology… more...
LCG Bioscience and the Harley Street Clinic are joining forces to provide sponsors with access to London clinical trials expertise, a diverse range of patient populations, major teaching hospital specialists and intensive care facilities outside the constraints of a National Health Service environment. LCG medical director Anthony Priestley says: “LCG… more...
Echo Therapeutics announced that it has signed a dermatology product and transdermal drug delivery technology right of first offer agreement with Cato BioVentures, the venture capital affiliate of Cato Research, a contract research and development organization. The agreement grants Echo exclusive rights of first negotiation to all dermatology product and… more...
A leading ethicist says contract research organizations (CROs) need more oversight. “CROs are just out there kind of doing their thing,” said Arthur Caplan of the University of Pennsylvania. “They need to be the object of more regulatory attention partly just to establish how well they are doing. It will… more...
Oramed Pharmaceuticals signed an agreement with OnQ consulting, a Johannesburg-based contract research organization (CRO), to conduct Phase IIB trials on its oral insulin capsules. The 30 subjects will each receive the treatment for a period of 6 weeks. Here is the news release. Paradigm Management Services, a provider of catastrophic… more...
WuXi PharmaTech, a contract research organization, endowed a new professorship in the Medical and Life Science School of Tongji University. Here are more details. Commonwealth Biotechnologies (CBI) announced a strategic alliance with New Zealand Pharmaceuticals (NZP) to provide small molecules. The alliance will focus on providing glycotherapeutic products and services… more...
Kendle, a clinical research organization, today announced the promotion of Simon Higginbotham to president. Chris Bergen, who previously served as president and chief operating officer, will continue as chief operating officer. In his new role, Higginbotham will provide global leadership for worldwide customer and business expansion to include strategic customer… more...
Two Democratic politicians hope to establish a separate federal institute to compare drugs in clinical trials. “Not enough credible, empirically based information is available for providers and payers to make decisions on alternative treatments and diagnostics for the most common conditions. New services become routine medical care without their comparative… more...